Solid Forms of 3-(6-(1-(2,2-Difluorobenzo[D][1,3]DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO)-3-Methylpyridin-2-YL)BENZOIC Acid
Vertex Pharmaceuticals Incorporated
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 8 of these applications claim priority to application 61/012,162, filed Dec 7, 2007. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,653,103 | Solid Forms of 3-(6-(1-(2,2-Difluorobenzo[D][1,3]DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO)-3-Methylpyridin-2-YL)BENZOIC Acid In force · High confidence UsedRemaining | Vertex Pharmaceuticals Incorporated | In force | High confidence | ||
| US 9,150,552 | Solid Forms of 3-(6-(1-(2,2-Difluorobenzo[D][1,3]DIOXOL-5-YL)CYCLOPROPANECARBOXAMIDO)-3-Methylpyridin-2-YL) Benzoic Acid In force · High confidence | Vertex Pharmaceuticals Incorporated | In force | High confidence | ||
| US 9,840,499 | Solid Forms of 3-(6-(1-(2,2-Difluorobenzo[D][1,3]DIOXOL-5-YL)CYCLOPROPANECARBOXAMIDO)-3-Methylpyridin-2-YL) Benzoic Acid In force · High confidence | Vertex Pharmaceuticals Incorporated | In force | High confidence | ||
| US 10,597,384 | Solid Forms of 3-(6-(1-(2,2-Difluorobenzo[D][1,3]DIOXOL-5-YL)CYCLOPROPANECARBOXAMIDO)-3-Methylpyridin-2-YL) Benzoic Acid In force · High confidence | Vertex Pharmaceuticals Incorporated | In force | High confidence | ||
| US 12,065,432 | Solid Forms of 3-(6-(1-(2,2-Difluorobenzo[D][1,3]DIOXOL-5-YL)CYCLOPROPANECARBOXAMIDO)-3-Methylpyridin-2-YL) Benzoic Acid In force · High confidence | Vertex Pharmaceuticals Incorporated | In force | High confidence | ||
| US 9,434,717 | Solid Forms of 3-(6-(1-(2,2-Difluorobenzo[D][1,3]DIOXOL-5-YL)CYCLOPROPANECARBOXAMIDO)-3-Methylpyridin-2-YL) Benzoic Acid In force · High confidence | Vertex Pharmaceuticals Incorporated | In force | High confidence | ||
| US 8,846,718 | Solid Forms of 3-(6-(1-(2,2-Difluorobenzo[D][1,3]DIOXOL-5-YL)CYCLOPROPANECARBOXAMIDO)-3-Methylpyridin-2-YL) Benzoic Acid In force · High confidence | Vertex Pharmaceuticals Incorporated | In force | High confidence | ||
| US 8,507,534 | Solid Forms of 3-(6-(1-(2,2-Difluorobenzo[D][1,3]DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO)-3-Methylpyridin-2-YL)BENZOIC Acid In force · High confidence | Vertex Pharmaceuticals Incorporated | In force | High confidence |
8 of 8 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.